Core Insights - Apogee Therapeutics (NASDAQ:APGE) is identified as one of the 17 biotechnology stocks with more than 50% upside potential, with a current price target of $95 set by Citi analyst Geoff Meacham, indicating a potential upside of over 37% [1] - RBC Capital analyst Brian Abrahams downgraded Apogee Therapeutics from Outperform to Sector Perform, while raising the price target from $70 to $83, suggesting nearly 20% upside [2] - The market reaction to the release of Sanofi's Phase 3 amlitelimab data is viewed as an overreaction, with Meacham asserting that it does not negatively impact the prospects for Apogee's APG279 candidate [1] Company Overview - Apogee Therapeutics is a clinical-stage biotechnology company focused on developing novel biologics for treating inflammatory and immune diseases, including atopic dermatitis, asthma, chronic obstructive pulmonary disease, and eosinophilic esophagitis [4] - The company's pipeline includes several candidates at different clinical trial stages, such as APG777, APG279, APG990, APG333, and APG808 [4] Market Context - The segment in which Apogee operates is becoming increasingly competitive, with established players posing challenges despite the potential of its primary drug, zumilokibart, as a long-acting IL-13 treatment for atopic dermatitis [3] - The share price of Apogee has surged by 108% over the past year, which may limit the potential for further gains [3]

The iShares Morningstar Small-Cap ETF ((NYSEMKT:ISCB)) and Vanguard Small-Cap ETF ((NYSEMKT:VB)) both offer broad U.S. small-cap exposure, but ISCB delivered stronger recent returns and holds more names, while VB is far larger, more liquid, and a touch less volatile. Both the iShares Morningstar Small-Cap ETF and Vanguard Small-Cap ETF aim to track the U.S. small-cap segment, providing investors with diversified access to hundreds of smaller companies. This comparison looks at how ISCB’s portfolio and ris ...

On February 12, 2026, Barington Companies Management disclosed a new position in Americold Realty Trust (NYSE:COLD), acquiring 300,000 shares in a transaction estimated at $3.86 million based on quarterly average pricing. What happened According to a SEC filing dated February 12, 2026, Barington Companies Management reported establishing a new position in Americold Realty Trust by purchasing 300,000 shares during the fourth quarter. The quarter-end value of the stake stood at $3.86 million, reflecting th ...

Turning 65 is a major milestone for one big reason -- it's when you're eligible for health coverage under Medicare. But if you're still working at age 65, Medicare coverage may not be necessary. If your job provides you with health insurance, you may still be able to sign up for Medicare and use it as secondary insurance. But that also may not be necessary. And since there's a cost to Medicare Part B, if you're still working at 65, you may decide to delay your enrollment. Will AI create the world's first ...

What happened According to a SEC filing dated Feb. 13, 2026, Chou Associates Management Inc. reduced its holding in SiriusXM Holdings Inc. (NASDAQ:SIRI) by 292,873 shares during the fourth quarter. The estimated value of the shares sold is $6.30 million, based on the average closing price over the quarter. The fund ended the period with 409,589 shares valued at $8.19 million. The overall position’s value dropped by $8.16 million, a figure that incorporates both trading activity and stock price changes. W ...

Traders are waiting on macroeconomic factors to signal Bitcoin’s next price move as the crypto market consolidates following its biggest fall in almost four years. Over the past month, Bitcoin slid some 28%, revisiting the levels it traded at before President Donald Trump’s 2024 election win. Since then, the top cryptocurrency has ping-ponged between $74,400 to $65,000 as investors wait for the dust to settle. Ben Harvey, a researcher at crypto investment firm Keyrock, told DL News he expects the next b ...

Quick Read Bitcoin dropped 2.3% across the past week as of Monday morning. That drop is higher than broad stock indexes like the S&P 500 and the Nasdaq. Coinbase CEO said on the company’s conference call this week that retail users “displayed diamond hands” by steadily purchasing Bitcoin during dips. A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here. Bitcoin traded for $68,674.29 on Monday morning, down ...

Amazon (NASDAQ: AMZN) is a well-known tech behemoth. Plenty of people use its commerce platform, and its name has become synonmous wth online shopping. Amazon is also competing in the artificial intelligence (AI) space, with its Amazon Web Services (AWS) cloud computing division. Despite operating in those lucrative areas, Amazon's growth rate has slowed a bit, and its stock price is underperforming. This opens it up to be passed by others who are operating at a high level. Two stocks that are crushing it ...

Addressing Apollo’s “Private Credit: Fact or Fiction?” white paper, Zelter said “private credit” is often narrowly defined by direct lending, but Apollo views it as much broader—encompassing assets that historically sat on bank balance sheets or were not part of liquid markets. He traced the rise of sponsor-backed direct lending as a third leg of non-investment-grade financing alongside high-yield bonds and leveraged loans, describing its growth from “zero to $2 trillion.”Using a golf analogy, Zelter said t ...

When one partner has more than $100,000 saved and zero debt, while the other is tens of thousands in debt, tension is almost inevitable. Add in expensive vacations and one person quietly footing every bill, and even a strong relationship can start to feel uneven. That was the dilemma shared by a young man on “The Ramsey Show” recently. He earns $135,000 a year, maxes out his 401(k) and has built six figures in savings. His girlfriend earns about $50,000 and carries between $70,000 and $80,000 in debt. He ...